Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
PharmAkea Extends Collaboration with Celgene Corporation
Saturday, November 19, 2016PharmAkea Inc announced the extension of their strategic collaboration with Celgene Corporation which was established to leverage PharmAkeas proprietary drug discovery platform and novel smallmolecule therapies targeting fibrotic diseases Under the...
Amgen, Novartis aim for big, crowded migraine market after new drug data
Friday, November 18, 2016Amgen Inc and Novartis said late on Wednesday that episodic migraine sufferers reported fewer debilitating headaches per month after using the companies investigational drug erenumab compared to trial participants who got a placebo The companies are...
WHO says funds secured for Africa pilots of world's first malaria vaccine
Friday, November 18, 2016Funding for phase one of pilot deployments of the worlds first malaria vaccine in subSaharan Africa has been secured and immunization campaigns will begin in the World Health Organization WHO said on Thursday The vaccine known as RTSS or Mosquirix...
Reviva Pharmaceuticals Receives FDA Orphan Designation for Pulmonary Arterial Hypertension (PAH)
Friday, November 18, 2016Reviva Pharmaceuticals Inc a privately held clinical stage pharmaceutical company today announced the granting of Orphan Drug Designation from the US Food and Drug Administration FDA for its lead development product RP for the treatment of pulmonary...
Japan sets 50 percent price cut for Bristol Myers' Opdivo cancer drug
Thursday, November 17, 2016Japans health ministry has set a percent cut in the price of Opdivo a costly immune systemboosting cancer drug produced by Bristol Myers Squibb Co and marketed in the country by Ono Pharmaceutical Co Ltd Ono Pharmaceutical said The halving of the p...
Amgen's migraine drug succeeds in late-stage trial
Thursday, November 17, 2016Amgen Inc said on Wednesday its migraine treatment met the main goal of reducing monthly migraine days in patients with episodic migraine in a second latestage study Patients receiving milligram of the drug erenumab experienced reduction of days f...
Bristol-Myers Squibb and Enterome announce immuno-oncology collaboration
Thursday, November 17, 2016BristolMyers Squibb and Enterome announce immunooncology collaboration focused on microbiomederived biomarkersdrug targets bioactive molecules BristolMyers Squibb BristolMyers Squibb will be granted exclusive rights to intellectual property and the...
Amgen cholesterol drug reduces artery-clogging plaque in study
Wednesday, November 16, 2016Amgen Incs potent new drug Repatha when added to statin therapy not only took bad LDL cholesterol down to extremely low levels but caused declines in arteryclogging plaque in a majority of highrisk heart patients after months of treatment according...
Corbus drug succeeds in mid-stage scleroderma study, shares surge
Tuesday, November 15, 2016Corbus Pharmaceuticals Holdings Inc said its only drug outperformed a placebo in a midstage study involving patients with a form of systemic sclerosis an incurable autoimmune condition caused by abnormal growth of connective tissue Shares of the Nor...
Richter's generic osteoporosis drug gets EU recommendation
Tuesday, November 15, 2016Richter received a positive opinion from European regulators recommending that its generic osteoporosis drug Terrosa be granted marketing authorization the Hungarian drug maker said in a statement on Monday Richter said the drug was its first biosim...
